Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3'-azido-2',3'-dideoxytbymidine

Ram P. Agarwal, Ofelia A. Olivero

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

AZT (3'-azido-2',3'-dideoxythymidine), the first nucleoside analog approved for the treatment of AIDS (acquired immunodeficiency syndrome), induces significant toxic effects in humans exposed to therapeutic doses. As an inhibitor of the HIV-1 (human immunodeficiency virus 1) reverse transcriptase, AZT blocks the incorporation of nucleotides into the host's newly synthesized DNA. Incorporation of AZT into mammalian DNA as well as specific localization of the drug into telomeric DNA, has been previously documented by immunohistochemistry. As with other nucleoside analogs, AZT has affinity for polymerase-@c, the enzyme responsible for the replication of mitochondrial DNA. In order to examine the mechanisms of toxic events induced by long-term AZT exposure, human T-lymphocytic H9 cells were cultured with 25 μM AZT for 7 months. In the resulting H(9-AZT), cells, incorporation of AZT into DNA was demonstrated by radioimmunoassay and immunohistochemistry chromosomal aberrations and micronuclei were scored and intracellular lipid distribution was determined. Two pmol of AZT per microgram of DNA were detected by radioimmunoassay in H(9-AZT) cells. Control cells showed negative values in the radioimmunoassay. Cytogenetic observations on H(9-AZT), cells showed an increase in chromosomal aberrations and nuclear fragmentation when compared with unexposed H9 cells. Electron microscopy revealed mitochondrial damage and an elevated accumulation of neutral intracellular lipid deposits probably as a consequence of a distortion in the β-oxidation of fatty acids normally carried out by this organelle. The toxicities explored here suggest that the mechanisms of AZT induced cytotoxicity in bone marrow of the patients chronically exposed to the drug in vivo may involve both chromosomal and mitochondrial DNA damage.

Original languageEnglish
Pages (from-to)223-231
Number of pages9
JournalMutation Research - Genetic Toxicology and Environmental Mutagenesis
Volume390
Issue number3
DOIs
StatePublished - May 23 1997
Externally publishedYes

Fingerprint

DNA
Radioimmunoassay
Poisons
Mitochondrial DNA
Nucleosides
Chromosome Aberrations
Immunohistochemistry
Lipids
Zidovudine
Cytogenetics
Pharmaceutical Preparations
Organelles
DNA Damage
Cultured Cells
Electron Microscopy
Acquired Immunodeficiency Syndrome
Fatty Acids
Nucleotides
Bone Marrow
Enzymes

Keywords

  • Mitochondrial DNA
  • Mitochondrium
  • Nucleoside analog

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Genetics

Cite this

Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3'-azido-2',3'-dideoxytbymidine. / Agarwal, Ram P.; Olivero, Ofelia A.

In: Mutation Research - Genetic Toxicology and Environmental Mutagenesis, Vol. 390, No. 3, 23.05.1997, p. 223-231.

Research output: Contribution to journalArticle

@article{af4245876cf34251bf7677cafd0e1688,
title = "Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3'-azido-2',3'-dideoxytbymidine",
abstract = "AZT (3'-azido-2',3'-dideoxythymidine), the first nucleoside analog approved for the treatment of AIDS (acquired immunodeficiency syndrome), induces significant toxic effects in humans exposed to therapeutic doses. As an inhibitor of the HIV-1 (human immunodeficiency virus 1) reverse transcriptase, AZT blocks the incorporation of nucleotides into the host's newly synthesized DNA. Incorporation of AZT into mammalian DNA as well as specific localization of the drug into telomeric DNA, has been previously documented by immunohistochemistry. As with other nucleoside analogs, AZT has affinity for polymerase-@c, the enzyme responsible for the replication of mitochondrial DNA. In order to examine the mechanisms of toxic events induced by long-term AZT exposure, human T-lymphocytic H9 cells were cultured with 25 μM AZT for 7 months. In the resulting H(9-AZT), cells, incorporation of AZT into DNA was demonstrated by radioimmunoassay and immunohistochemistry chromosomal aberrations and micronuclei were scored and intracellular lipid distribution was determined. Two pmol of AZT per microgram of DNA were detected by radioimmunoassay in H(9-AZT) cells. Control cells showed negative values in the radioimmunoassay. Cytogenetic observations on H(9-AZT), cells showed an increase in chromosomal aberrations and nuclear fragmentation when compared with unexposed H9 cells. Electron microscopy revealed mitochondrial damage and an elevated accumulation of neutral intracellular lipid deposits probably as a consequence of a distortion in the β-oxidation of fatty acids normally carried out by this organelle. The toxicities explored here suggest that the mechanisms of AZT induced cytotoxicity in bone marrow of the patients chronically exposed to the drug in vivo may involve both chromosomal and mitochondrial DNA damage.",
keywords = "Mitochondrial DNA, Mitochondrium, Nucleoside analog",
author = "Agarwal, {Ram P.} and Olivero, {Ofelia A.}",
year = "1997",
month = "5",
day = "23",
doi = "10.1016/S1383-5718(97)00014-4",
language = "English",
volume = "390",
pages = "223--231",
journal = "Mutation Research - Genetic Toxicology and Environmental Mutagenesis",
issn = "1383-5718",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3'-azido-2',3'-dideoxytbymidine

AU - Agarwal, Ram P.

AU - Olivero, Ofelia A.

PY - 1997/5/23

Y1 - 1997/5/23

N2 - AZT (3'-azido-2',3'-dideoxythymidine), the first nucleoside analog approved for the treatment of AIDS (acquired immunodeficiency syndrome), induces significant toxic effects in humans exposed to therapeutic doses. As an inhibitor of the HIV-1 (human immunodeficiency virus 1) reverse transcriptase, AZT blocks the incorporation of nucleotides into the host's newly synthesized DNA. Incorporation of AZT into mammalian DNA as well as specific localization of the drug into telomeric DNA, has been previously documented by immunohistochemistry. As with other nucleoside analogs, AZT has affinity for polymerase-@c, the enzyme responsible for the replication of mitochondrial DNA. In order to examine the mechanisms of toxic events induced by long-term AZT exposure, human T-lymphocytic H9 cells were cultured with 25 μM AZT for 7 months. In the resulting H(9-AZT), cells, incorporation of AZT into DNA was demonstrated by radioimmunoassay and immunohistochemistry chromosomal aberrations and micronuclei were scored and intracellular lipid distribution was determined. Two pmol of AZT per microgram of DNA were detected by radioimmunoassay in H(9-AZT) cells. Control cells showed negative values in the radioimmunoassay. Cytogenetic observations on H(9-AZT), cells showed an increase in chromosomal aberrations and nuclear fragmentation when compared with unexposed H9 cells. Electron microscopy revealed mitochondrial damage and an elevated accumulation of neutral intracellular lipid deposits probably as a consequence of a distortion in the β-oxidation of fatty acids normally carried out by this organelle. The toxicities explored here suggest that the mechanisms of AZT induced cytotoxicity in bone marrow of the patients chronically exposed to the drug in vivo may involve both chromosomal and mitochondrial DNA damage.

AB - AZT (3'-azido-2',3'-dideoxythymidine), the first nucleoside analog approved for the treatment of AIDS (acquired immunodeficiency syndrome), induces significant toxic effects in humans exposed to therapeutic doses. As an inhibitor of the HIV-1 (human immunodeficiency virus 1) reverse transcriptase, AZT blocks the incorporation of nucleotides into the host's newly synthesized DNA. Incorporation of AZT into mammalian DNA as well as specific localization of the drug into telomeric DNA, has been previously documented by immunohistochemistry. As with other nucleoside analogs, AZT has affinity for polymerase-@c, the enzyme responsible for the replication of mitochondrial DNA. In order to examine the mechanisms of toxic events induced by long-term AZT exposure, human T-lymphocytic H9 cells were cultured with 25 μM AZT for 7 months. In the resulting H(9-AZT), cells, incorporation of AZT into DNA was demonstrated by radioimmunoassay and immunohistochemistry chromosomal aberrations and micronuclei were scored and intracellular lipid distribution was determined. Two pmol of AZT per microgram of DNA were detected by radioimmunoassay in H(9-AZT) cells. Control cells showed negative values in the radioimmunoassay. Cytogenetic observations on H(9-AZT), cells showed an increase in chromosomal aberrations and nuclear fragmentation when compared with unexposed H9 cells. Electron microscopy revealed mitochondrial damage and an elevated accumulation of neutral intracellular lipid deposits probably as a consequence of a distortion in the β-oxidation of fatty acids normally carried out by this organelle. The toxicities explored here suggest that the mechanisms of AZT induced cytotoxicity in bone marrow of the patients chronically exposed to the drug in vivo may involve both chromosomal and mitochondrial DNA damage.

KW - Mitochondrial DNA

KW - Mitochondrium

KW - Nucleoside analog

UR - http://www.scopus.com/inward/record.url?scp=0030994880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030994880&partnerID=8YFLogxK

U2 - 10.1016/S1383-5718(97)00014-4

DO - 10.1016/S1383-5718(97)00014-4

M3 - Article

C2 - 9186571

AN - SCOPUS:0030994880

VL - 390

SP - 223

EP - 231

JO - Mutation Research - Genetic Toxicology and Environmental Mutagenesis

JF - Mutation Research - Genetic Toxicology and Environmental Mutagenesis

SN - 1383-5718

IS - 3

ER -